CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Infliximab induction and maintenance therapy for ulcerative colitis: the ACT 2 trial
DOI 10.1055/s-2005-869606
Bibliografische Angaben
Nachweis in CareLit
Autor:innenWJ Sandborn, W Reinisch, D Rachmilewitz, SB Hanauer, GR Lichtenstein, WJS de Villiers, A Olson, J Johanns, S Travers, JF Colombel
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: The efficacy of infliximab (IFX) for the treatment of ulcerative colitis (UC) was previously unknown. Two Phase 3 trials, ACT I and ACT 2, evaluated the safety and efficacy of IFX for treatment of active UC. Results from ACT 2 are presented. Methods: 364 patients with UC, refractory to at least one standard therapy including 5-ASA, corticosteroids, or immunosuppressants, were randomized to receive IFX 5…
Zitieren
Zitierempfehlung
WJ Sandborn, W Reinisch, D Rachmilewitz, SB Hanauer, GR Lichtenstein, WJS de Villiers, A Olson, J Johanns, S Travers, JF Colombel (2005) Infliximab induction and maintenance therapy for ulcerative colitis: the ACT 2 trial. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-2005-869606
Mit CareLit weiterarbeiten